STOCKHOLM, Sweden, June 12 – Following on a strong year-end report, Elekta presented a very positive outlook for the coming years at its Capital Markets Day in Stockholm.
Elekta President and CEO, Tomas Puusepp, opened the meeting by presenting statistics that support Elekta’s stronger position in all markets and he restated the company’s ambition of two million patients being treated with Elekta solutions every year.

“We have continued our fast growth in emerging markets and also strengthening our positions in established markets. During the next three years our ambition is to grow net sales by 40* percent,” he told the audience of about 100 investors and analysts. “We are the leader in the majority of these markets and we are investing further to help patients live better lives.

“We’ve strengthened our position in established markets and have grown faster than the competition. Asia has shown good growth and China is now our second largest market in Elekta.” Puusepp said the...